nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CYP2A6—prostate cancer	0.197	0.464	CbGaD
Pilocarpine—CYP2E1—prostate cancer	0.14	0.329	CbGaD
Pilocarpine—CYP3A4—prostate cancer	0.0881	0.207	CbGaD
Pilocarpine—CYP2E1—Estrone—prostate cancer	0.0432	0.151	CbGbCtD
Pilocarpine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0416	0.145	CbGbCtD
Pilocarpine—CYP2E1—Mitoxantrone—prostate cancer	0.0257	0.0897	CbGbCtD
Pilocarpine—CYP3A4—Bicalutamide—prostate cancer	0.0219	0.0763	CbGbCtD
Pilocarpine—CYP3A4—Estramustine—prostate cancer	0.0203	0.071	CbGbCtD
Pilocarpine—CYP3A4—Flutamide—prostate cancer	0.0181	0.0632	CbGbCtD
Pilocarpine—CYP3A4—Abiraterone—prostate cancer	0.0181	0.0632	CbGbCtD
Pilocarpine—CYP2E1—Etoposide—prostate cancer	0.0162	0.0566	CbGbCtD
Pilocarpine—CYP3A4—Cabazitaxel—prostate cancer	0.0134	0.0468	CbGbCtD
Pilocarpine—CYP3A4—Estrone—prostate cancer	0.0131	0.0457	CbGbCtD
Pilocarpine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0117	0.0408	CbGbCtD
Pilocarpine—CHRM3—ureter—prostate cancer	0.0106	0.378	CbGeAlD
Pilocarpine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00857	0.0299	CbGbCtD
Pilocarpine—CYP3A4—Mitoxantrone—prostate cancer	0.00779	0.0272	CbGbCtD
Pilocarpine—CYP3A4—Estradiol—prostate cancer	0.00752	0.0263	CbGbCtD
Pilocarpine—CYP3A4—Prednisone—prostate cancer	0.00647	0.0226	CbGbCtD
Pilocarpine—CYP3A4—Etoposide—prostate cancer	0.00491	0.0171	CbGbCtD
Pilocarpine—CYP3A4—Docetaxel—prostate cancer	0.00449	0.0157	CbGbCtD
Pilocarpine—CYP3A4—Doxorubicin—prostate cancer	0.00335	0.0117	CbGbCtD
Pilocarpine—CYP2E1—urine—prostate cancer	0.00235	0.0839	CbGeAlD
Pilocarpine—CYP3A4—urine—prostate cancer	0.00189	0.0675	CbGeAlD
Pilocarpine—CYP2A6—prostate gland—prostate cancer	0.00179	0.0637	CbGeAlD
Pilocarpine—CHRM2—prostate gland—prostate cancer	0.00152	0.0542	CbGeAlD
Pilocarpine—CYP2A6—seminal vesicle—prostate cancer	0.00151	0.0539	CbGeAlD
Pilocarpine—CHRM1—prostate gland—prostate cancer	0.00138	0.0493	CbGeAlD
Pilocarpine—CHRM3—prostate gland—prostate cancer	0.00124	0.0441	CbGeAlD
Pilocarpine—CYP2E1—prostate gland—prostate cancer	0.000845	0.0301	CbGeAlD
Pilocarpine—CHRM3—renal system—prostate cancer	0.000843	0.0301	CbGeAlD
Pilocarpine—CHRM3—urethra—prostate cancer	0.000828	0.0295	CbGeAlD
Pilocarpine—CYP2E1—seminal vesicle—prostate cancer	0.000714	0.0255	CbGeAlD
Pilocarpine—CYP2E1—renal system—prostate cancer	0.000576	0.0205	CbGeAlD
Pilocarpine—CYP2E1—urethra—prostate cancer	0.000565	0.0202	CbGeAlD
Pilocarpine—CHRM3—testis—prostate cancer	0.000545	0.0194	CbGeAlD
Pilocarpine—CYP3A4—renal system—prostate cancer	0.000463	0.0165	CbGeAlD
Pilocarpine—CYP2E1—testis—prostate cancer	0.000372	0.0133	CbGeAlD
Pilocarpine—Dermatitis—Estradiol—prostate cancer	4.15e-05	0.00023	CcSEcCtD
Pilocarpine—Confusional state—Capecitabine—prostate cancer	4.14e-05	0.00023	CcSEcCtD
Pilocarpine—Tachycardia—Docetaxel—prostate cancer	4.14e-05	0.00023	CcSEcCtD
Pilocarpine—Headache—Estradiol—prostate cancer	4.13e-05	0.000229	CcSEcCtD
Pilocarpine—Agitation—Prednisone—prostate cancer	4.12e-05	0.000229	CcSEcCtD
Pilocarpine—Oedema—Capecitabine—prostate cancer	4.11e-05	0.000228	CcSEcCtD
Pilocarpine—Bradycardia—Epirubicin—prostate cancer	4.1e-05	0.000228	CcSEcCtD
Pilocarpine—Infection—Capecitabine—prostate cancer	4.08e-05	0.000227	CcSEcCtD
Pilocarpine—Stomatitis—Doxorubicin—prostate cancer	4.05e-05	0.000225	CcSEcCtD
Pilocarpine—Anorexia—Docetaxel—prostate cancer	4.05e-05	0.000225	CcSEcCtD
Pilocarpine—Shock—Capecitabine—prostate cancer	4.04e-05	0.000224	CcSEcCtD
Pilocarpine—Rhinitis—Epirubicin—prostate cancer	4.04e-05	0.000224	CcSEcCtD
Pilocarpine—Abdominal pain—Etoposide—prostate cancer	4.04e-05	0.000224	CcSEcCtD
Pilocarpine—Body temperature increased—Etoposide—prostate cancer	4.04e-05	0.000224	CcSEcCtD
Pilocarpine—Urinary tract infection—Doxorubicin—prostate cancer	4.04e-05	0.000224	CcSEcCtD
Pilocarpine—Conjunctivitis—Doxorubicin—prostate cancer	4.04e-05	0.000224	CcSEcCtD
Pilocarpine—Hepatitis—Epirubicin—prostate cancer	4.03e-05	0.000224	CcSEcCtD
Pilocarpine—Thrombocytopenia—Capecitabine—prostate cancer	4.02e-05	0.000223	CcSEcCtD
Pilocarpine—Syncope—Prednisone—prostate cancer	4.02e-05	0.000223	CcSEcCtD
Pilocarpine—Tachycardia—Capecitabine—prostate cancer	4.01e-05	0.000223	CcSEcCtD
Pilocarpine—Hypoaesthesia—Epirubicin—prostate cancer	4.01e-05	0.000223	CcSEcCtD
Pilocarpine—Pharyngitis—Epirubicin—prostate cancer	4e-05	0.000222	CcSEcCtD
Pilocarpine—Sweating—Doxorubicin—prostate cancer	3.98e-05	0.000221	CcSEcCtD
Pilocarpine—Hyperhidrosis—Capecitabine—prostate cancer	3.97e-05	0.000221	CcSEcCtD
Pilocarpine—Oedema peripheral—Epirubicin—prostate cancer	3.97e-05	0.00022	CcSEcCtD
Pilocarpine—Hypotension—Docetaxel—prostate cancer	3.97e-05	0.00022	CcSEcCtD
Pilocarpine—Haematuria—Doxorubicin—prostate cancer	3.96e-05	0.00022	CcSEcCtD
Pilocarpine—Loss of consciousness—Prednisone—prostate cancer	3.94e-05	0.000219	CcSEcCtD
Pilocarpine—Epistaxis—Doxorubicin—prostate cancer	3.92e-05	0.000217	CcSEcCtD
Pilocarpine—Anorexia—Capecitabine—prostate cancer	3.92e-05	0.000217	CcSEcCtD
Pilocarpine—Nausea—Estradiol—prostate cancer	3.91e-05	0.000217	CcSEcCtD
Pilocarpine—Vomiting—Mitoxantrone—prostate cancer	3.9e-05	0.000217	CcSEcCtD
Pilocarpine—Sinusitis—Doxorubicin—prostate cancer	3.9e-05	0.000216	CcSEcCtD
Pilocarpine—Visual impairment—Epirubicin—prostate cancer	3.88e-05	0.000216	CcSEcCtD
Pilocarpine—Hypertension—Prednisone—prostate cancer	3.87e-05	0.000215	CcSEcCtD
Pilocarpine—Rash—Mitoxantrone—prostate cancer	3.87e-05	0.000215	CcSEcCtD
Pilocarpine—Dermatitis—Mitoxantrone—prostate cancer	3.87e-05	0.000215	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.87e-05	0.000215	CcSEcCtD
Pilocarpine—Headache—Mitoxantrone—prostate cancer	3.85e-05	0.000214	CcSEcCtD
Pilocarpine—Hypotension—Capecitabine—prostate cancer	3.84e-05	0.000213	CcSEcCtD
Pilocarpine—Insomnia—Docetaxel—prostate cancer	3.84e-05	0.000213	CcSEcCtD
Pilocarpine—Myalgia—Prednisone—prostate cancer	3.82e-05	0.000212	CcSEcCtD
Pilocarpine—Arthralgia—Prednisone—prostate cancer	3.82e-05	0.000212	CcSEcCtD
Pilocarpine—Paraesthesia—Docetaxel—prostate cancer	3.81e-05	0.000212	CcSEcCtD
Pilocarpine—Anxiety—Prednisone—prostate cancer	3.8e-05	0.000211	CcSEcCtD
Pilocarpine—Bradycardia—Doxorubicin—prostate cancer	3.8e-05	0.000211	CcSEcCtD
Pilocarpine—Dyspnoea—Docetaxel—prostate cancer	3.78e-05	0.00021	CcSEcCtD
Pilocarpine—Somnolence—Docetaxel—prostate cancer	3.77e-05	0.000209	CcSEcCtD
Pilocarpine—Discomfort—Prednisone—prostate cancer	3.77e-05	0.000209	CcSEcCtD
Pilocarpine—Eye disorder—Epirubicin—prostate cancer	3.77e-05	0.000209	CcSEcCtD
Pilocarpine—Hypersensitivity—Etoposide—prostate cancer	3.76e-05	0.000209	CcSEcCtD
Pilocarpine—Tinnitus—Epirubicin—prostate cancer	3.76e-05	0.000209	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.74e-05	0.000208	CcSEcCtD
Pilocarpine—Flushing—Epirubicin—prostate cancer	3.74e-05	0.000208	CcSEcCtD
Pilocarpine—Rhinitis—Doxorubicin—prostate cancer	3.74e-05	0.000207	CcSEcCtD
Pilocarpine—Dyspepsia—Docetaxel—prostate cancer	3.74e-05	0.000207	CcSEcCtD
Pilocarpine—Hepatitis—Doxorubicin—prostate cancer	3.73e-05	0.000207	CcSEcCtD
Pilocarpine—Insomnia—Capecitabine—prostate cancer	3.72e-05	0.000206	CcSEcCtD
Pilocarpine—Hypoaesthesia—Doxorubicin—prostate cancer	3.71e-05	0.000206	CcSEcCtD
Pilocarpine—Pharyngitis—Doxorubicin—prostate cancer	3.7e-05	0.000205	CcSEcCtD
Pilocarpine—Paraesthesia—Capecitabine—prostate cancer	3.69e-05	0.000205	CcSEcCtD
Pilocarpine—Decreased appetite—Docetaxel—prostate cancer	3.69e-05	0.000205	CcSEcCtD
Pilocarpine—Oedema peripheral—Doxorubicin—prostate cancer	3.67e-05	0.000204	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Docetaxel—prostate cancer	3.66e-05	0.000203	CcSEcCtD
Pilocarpine—Asthenia—Etoposide—prostate cancer	3.66e-05	0.000203	CcSEcCtD
Pilocarpine—Dyspnoea—Capecitabine—prostate cancer	3.66e-05	0.000203	CcSEcCtD
Pilocarpine—Oedema—Prednisone—prostate cancer	3.66e-05	0.000203	CcSEcCtD
Pilocarpine—Nausea—Mitoxantrone—prostate cancer	3.65e-05	0.000202	CcSEcCtD
Pilocarpine—Infection—Prednisone—prostate cancer	3.64e-05	0.000202	CcSEcCtD
Pilocarpine—Constipation—Docetaxel—prostate cancer	3.63e-05	0.000201	CcSEcCtD
Pilocarpine—Pain—Docetaxel—prostate cancer	3.63e-05	0.000201	CcSEcCtD
Pilocarpine—Dyspepsia—Capecitabine—prostate cancer	3.62e-05	0.000201	CcSEcCtD
Pilocarpine—Chills—Epirubicin—prostate cancer	3.62e-05	0.000201	CcSEcCtD
Pilocarpine—Pruritus—Etoposide—prostate cancer	3.61e-05	0.000201	CcSEcCtD
Pilocarpine—Shock—Prednisone—prostate cancer	3.6e-05	0.0002	CcSEcCtD
Pilocarpine—Arrhythmia—Epirubicin—prostate cancer	3.6e-05	0.0002	CcSEcCtD
Pilocarpine—Visual impairment—Doxorubicin—prostate cancer	3.59e-05	0.000199	CcSEcCtD
Pilocarpine—Tachycardia—Prednisone—prostate cancer	3.57e-05	0.000198	CcSEcCtD
Pilocarpine—Decreased appetite—Capecitabine—prostate cancer	3.57e-05	0.000198	CcSEcCtD
Pilocarpine—Alopecia—Epirubicin—prostate cancer	3.56e-05	0.000198	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Capecitabine—prostate cancer	3.55e-05	0.000197	CcSEcCtD
Pilocarpine—Hyperhidrosis—Prednisone—prostate cancer	3.54e-05	0.000196	CcSEcCtD
Pilocarpine—Constipation—Capecitabine—prostate cancer	3.51e-05	0.000195	CcSEcCtD
Pilocarpine—Pain—Capecitabine—prostate cancer	3.51e-05	0.000195	CcSEcCtD
Pilocarpine—Feeling abnormal—Docetaxel—prostate cancer	3.5e-05	0.000194	CcSEcCtD
Pilocarpine—Diarrhoea—Etoposide—prostate cancer	3.49e-05	0.000194	CcSEcCtD
Pilocarpine—Anorexia—Prednisone—prostate cancer	3.49e-05	0.000194	CcSEcCtD
Pilocarpine—Eye disorder—Doxorubicin—prostate cancer	3.48e-05	0.000193	CcSEcCtD
Pilocarpine—Tinnitus—Doxorubicin—prostate cancer	3.48e-05	0.000193	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Docetaxel—prostate cancer	3.47e-05	0.000193	CcSEcCtD
Pilocarpine—Flushing—Doxorubicin—prostate cancer	3.46e-05	0.000192	CcSEcCtD
Pilocarpine—Flatulence—Epirubicin—prostate cancer	3.46e-05	0.000192	CcSEcCtD
Pilocarpine—Tension—Epirubicin—prostate cancer	3.44e-05	0.000191	CcSEcCtD
Pilocarpine—Dysgeusia—Epirubicin—prostate cancer	3.43e-05	0.000191	CcSEcCtD
Pilocarpine—Nervousness—Epirubicin—prostate cancer	3.41e-05	0.000189	CcSEcCtD
Pilocarpine—Back pain—Epirubicin—prostate cancer	3.39e-05	0.000188	CcSEcCtD
Pilocarpine—Feeling abnormal—Capecitabine—prostate cancer	3.39e-05	0.000188	CcSEcCtD
Pilocarpine—Dizziness—Etoposide—prostate cancer	3.38e-05	0.000187	CcSEcCtD
Pilocarpine—Muscle spasms—Epirubicin—prostate cancer	3.37e-05	0.000187	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Capecitabine—prostate cancer	3.36e-05	0.000187	CcSEcCtD
Pilocarpine—Abdominal pain—Docetaxel—prostate cancer	3.35e-05	0.000186	CcSEcCtD
Pilocarpine—Body temperature increased—Docetaxel—prostate cancer	3.35e-05	0.000186	CcSEcCtD
Pilocarpine—Chills—Doxorubicin—prostate cancer	3.34e-05	0.000186	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Prednisone—prostate cancer	3.33e-05	0.000185	CcSEcCtD
Pilocarpine—Arrhythmia—Doxorubicin—prostate cancer	3.33e-05	0.000185	CcSEcCtD
Pilocarpine—Insomnia—Prednisone—prostate cancer	3.31e-05	0.000184	CcSEcCtD
Pilocarpine—Vision blurred—Epirubicin—prostate cancer	3.31e-05	0.000184	CcSEcCtD
Pilocarpine—Alopecia—Doxorubicin—prostate cancer	3.29e-05	0.000183	CcSEcCtD
Pilocarpine—Paraesthesia—Prednisone—prostate cancer	3.29e-05	0.000182	CcSEcCtD
Pilocarpine—Body temperature increased—Capecitabine—prostate cancer	3.25e-05	0.00018	CcSEcCtD
Pilocarpine—Abdominal pain—Capecitabine—prostate cancer	3.25e-05	0.00018	CcSEcCtD
Pilocarpine—Vomiting—Etoposide—prostate cancer	3.25e-05	0.00018	CcSEcCtD
Pilocarpine—Agitation—Epirubicin—prostate cancer	3.22e-05	0.000179	CcSEcCtD
Pilocarpine—Dyspepsia—Prednisone—prostate cancer	3.22e-05	0.000179	CcSEcCtD
Pilocarpine—Rash—Etoposide—prostate cancer	3.22e-05	0.000179	CcSEcCtD
Pilocarpine—Dermatitis—Etoposide—prostate cancer	3.22e-05	0.000179	CcSEcCtD
Pilocarpine—Headache—Etoposide—prostate cancer	3.2e-05	0.000178	CcSEcCtD
Pilocarpine—Flatulence—Doxorubicin—prostate cancer	3.2e-05	0.000178	CcSEcCtD
Pilocarpine—Tension—Doxorubicin—prostate cancer	3.18e-05	0.000177	CcSEcCtD
Pilocarpine—Decreased appetite—Prednisone—prostate cancer	3.18e-05	0.000177	CcSEcCtD
Pilocarpine—Dysgeusia—Doxorubicin—prostate cancer	3.18e-05	0.000176	CcSEcCtD
Pilocarpine—Nervousness—Doxorubicin—prostate cancer	3.15e-05	0.000175	CcSEcCtD
Pilocarpine—Syncope—Epirubicin—prostate cancer	3.15e-05	0.000175	CcSEcCtD
Pilocarpine—Leukopenia—Epirubicin—prostate cancer	3.14e-05	0.000174	CcSEcCtD
Pilocarpine—Back pain—Doxorubicin—prostate cancer	3.14e-05	0.000174	CcSEcCtD
Pilocarpine—Constipation—Prednisone—prostate cancer	3.13e-05	0.000174	CcSEcCtD
Pilocarpine—Hypersensitivity—Docetaxel—prostate cancer	3.13e-05	0.000174	CcSEcCtD
Pilocarpine—Muscle spasms—Doxorubicin—prostate cancer	3.12e-05	0.000173	CcSEcCtD
Pilocarpine—Palpitations—Epirubicin—prostate cancer	3.1e-05	0.000172	CcSEcCtD
Pilocarpine—Loss of consciousness—Epirubicin—prostate cancer	3.08e-05	0.000171	CcSEcCtD
Pilocarpine—Cough—Epirubicin—prostate cancer	3.06e-05	0.00017	CcSEcCtD
Pilocarpine—Vision blurred—Doxorubicin—prostate cancer	3.06e-05	0.00017	CcSEcCtD
Pilocarpine—Asthenia—Docetaxel—prostate cancer	3.04e-05	0.000169	CcSEcCtD
Pilocarpine—Nausea—Etoposide—prostate cancer	3.03e-05	0.000168	CcSEcCtD
Pilocarpine—Hypertension—Epirubicin—prostate cancer	3.03e-05	0.000168	CcSEcCtD
Pilocarpine—Hypersensitivity—Capecitabine—prostate cancer	3.03e-05	0.000168	CcSEcCtD
Pilocarpine—Feeling abnormal—Prednisone—prostate cancer	3.02e-05	0.000167	CcSEcCtD
Pilocarpine—Pruritus—Docetaxel—prostate cancer	3e-05	0.000167	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Prednisone—prostate cancer	2.99e-05	0.000166	CcSEcCtD
Pilocarpine—Chest pain—Epirubicin—prostate cancer	2.99e-05	0.000166	CcSEcCtD
Pilocarpine—Arthralgia—Epirubicin—prostate cancer	2.99e-05	0.000166	CcSEcCtD
Pilocarpine—Myalgia—Epirubicin—prostate cancer	2.99e-05	0.000166	CcSEcCtD
Pilocarpine—Agitation—Doxorubicin—prostate cancer	2.98e-05	0.000166	CcSEcCtD
Pilocarpine—Anxiety—Epirubicin—prostate cancer	2.98e-05	0.000165	CcSEcCtD
Pilocarpine—Discomfort—Epirubicin—prostate cancer	2.95e-05	0.000164	CcSEcCtD
Pilocarpine—Asthenia—Capecitabine—prostate cancer	2.95e-05	0.000164	CcSEcCtD
Pilocarpine—Syncope—Doxorubicin—prostate cancer	2.91e-05	0.000162	CcSEcCtD
Pilocarpine—Pruritus—Capecitabine—prostate cancer	2.91e-05	0.000161	CcSEcCtD
Pilocarpine—Leukopenia—Doxorubicin—prostate cancer	2.9e-05	0.000161	CcSEcCtD
Pilocarpine—Diarrhoea—Docetaxel—prostate cancer	2.9e-05	0.000161	CcSEcCtD
Pilocarpine—Abdominal pain—Prednisone—prostate cancer	2.89e-05	0.000161	CcSEcCtD
Pilocarpine—Body temperature increased—Prednisone—prostate cancer	2.89e-05	0.000161	CcSEcCtD
Pilocarpine—Confusional state—Epirubicin—prostate cancer	2.89e-05	0.00016	CcSEcCtD
Pilocarpine—Palpitations—Doxorubicin—prostate cancer	2.87e-05	0.000159	CcSEcCtD
Pilocarpine—Oedema—Epirubicin—prostate cancer	2.86e-05	0.000159	CcSEcCtD
Pilocarpine—Loss of consciousness—Doxorubicin—prostate cancer	2.85e-05	0.000158	CcSEcCtD
Pilocarpine—Infection—Epirubicin—prostate cancer	2.84e-05	0.000158	CcSEcCtD
Pilocarpine—Cough—Doxorubicin—prostate cancer	2.83e-05	0.000157	CcSEcCtD
Pilocarpine—Shock—Epirubicin—prostate cancer	2.82e-05	0.000156	CcSEcCtD
Pilocarpine—Diarrhoea—Capecitabine—prostate cancer	2.81e-05	0.000156	CcSEcCtD
Pilocarpine—Dizziness—Docetaxel—prostate cancer	2.81e-05	0.000156	CcSEcCtD
Pilocarpine—Thrombocytopenia—Epirubicin—prostate cancer	2.8e-05	0.000156	CcSEcCtD
Pilocarpine—Hypertension—Doxorubicin—prostate cancer	2.8e-05	0.000156	CcSEcCtD
Pilocarpine—Tachycardia—Epirubicin—prostate cancer	2.79e-05	0.000155	CcSEcCtD
Pilocarpine—Hyperhidrosis—Epirubicin—prostate cancer	2.77e-05	0.000154	CcSEcCtD
Pilocarpine—Chest pain—Doxorubicin—prostate cancer	2.76e-05	0.000153	CcSEcCtD
Pilocarpine—Arthralgia—Doxorubicin—prostate cancer	2.76e-05	0.000153	CcSEcCtD
Pilocarpine—Myalgia—Doxorubicin—prostate cancer	2.76e-05	0.000153	CcSEcCtD
Pilocarpine—Anxiety—Doxorubicin—prostate cancer	2.75e-05	0.000153	CcSEcCtD
Pilocarpine—Discomfort—Doxorubicin—prostate cancer	2.73e-05	0.000152	CcSEcCtD
Pilocarpine—Anorexia—Epirubicin—prostate cancer	2.73e-05	0.000151	CcSEcCtD
Pilocarpine—Dizziness—Capecitabine—prostate cancer	2.72e-05	0.000151	CcSEcCtD
Pilocarpine—Vomiting—Docetaxel—prostate cancer	2.7e-05	0.00015	CcSEcCtD
Pilocarpine—Hypersensitivity—Prednisone—prostate cancer	2.7e-05	0.00015	CcSEcCtD
Pilocarpine—Rash—Docetaxel—prostate cancer	2.68e-05	0.000149	CcSEcCtD
Pilocarpine—Hypotension—Epirubicin—prostate cancer	2.67e-05	0.000149	CcSEcCtD
Pilocarpine—Dermatitis—Docetaxel—prostate cancer	2.67e-05	0.000148	CcSEcCtD
Pilocarpine—Confusional state—Doxorubicin—prostate cancer	2.67e-05	0.000148	CcSEcCtD
Pilocarpine—Headache—Docetaxel—prostate cancer	2.66e-05	0.000148	CcSEcCtD
Pilocarpine—Oedema—Doxorubicin—prostate cancer	2.65e-05	0.000147	CcSEcCtD
Pilocarpine—Infection—Doxorubicin—prostate cancer	2.63e-05	0.000146	CcSEcCtD
Pilocarpine—Asthenia—Prednisone—prostate cancer	2.63e-05	0.000146	CcSEcCtD
Pilocarpine—Vomiting—Capecitabine—prostate cancer	2.61e-05	0.000145	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.61e-05	0.000145	CcSEcCtD
Pilocarpine—Shock—Doxorubicin—prostate cancer	2.61e-05	0.000145	CcSEcCtD
Pilocarpine—Thrombocytopenia—Doxorubicin—prostate cancer	2.59e-05	0.000144	CcSEcCtD
Pilocarpine—Rash—Capecitabine—prostate cancer	2.59e-05	0.000144	CcSEcCtD
Pilocarpine—Pruritus—Prednisone—prostate cancer	2.59e-05	0.000144	CcSEcCtD
Pilocarpine—Insomnia—Epirubicin—prostate cancer	2.59e-05	0.000144	CcSEcCtD
Pilocarpine—Dermatitis—Capecitabine—prostate cancer	2.59e-05	0.000144	CcSEcCtD
Pilocarpine—Tachycardia—Doxorubicin—prostate cancer	2.58e-05	0.000144	CcSEcCtD
Pilocarpine—Headache—Capecitabine—prostate cancer	2.57e-05	0.000143	CcSEcCtD
Pilocarpine—Paraesthesia—Epirubicin—prostate cancer	2.57e-05	0.000143	CcSEcCtD
Pilocarpine—Hyperhidrosis—Doxorubicin—prostate cancer	2.56e-05	0.000142	CcSEcCtD
Pilocarpine—Dyspnoea—Epirubicin—prostate cancer	2.55e-05	0.000142	CcSEcCtD
Pilocarpine—Somnolence—Epirubicin—prostate cancer	2.54e-05	0.000141	CcSEcCtD
Pilocarpine—Anorexia—Doxorubicin—prostate cancer	2.52e-05	0.00014	CcSEcCtD
Pilocarpine—Nausea—Docetaxel—prostate cancer	2.52e-05	0.00014	CcSEcCtD
Pilocarpine—Dyspepsia—Epirubicin—prostate cancer	2.52e-05	0.00014	CcSEcCtD
Pilocarpine—Diarrhoea—Prednisone—prostate cancer	2.5e-05	0.000139	CcSEcCtD
Pilocarpine—Decreased appetite—Epirubicin—prostate cancer	2.49e-05	0.000138	CcSEcCtD
Pilocarpine—Hypotension—Doxorubicin—prostate cancer	2.47e-05	0.000137	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Epirubicin—prostate cancer	2.47e-05	0.000137	CcSEcCtD
Pilocarpine—Constipation—Epirubicin—prostate cancer	2.45e-05	0.000136	CcSEcCtD
Pilocarpine—Pain—Epirubicin—prostate cancer	2.45e-05	0.000136	CcSEcCtD
Pilocarpine—Nausea—Capecitabine—prostate cancer	2.44e-05	0.000136	CcSEcCtD
Pilocarpine—Dizziness—Prednisone—prostate cancer	2.42e-05	0.000134	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.41e-05	0.000134	CcSEcCtD
Pilocarpine—Insomnia—Doxorubicin—prostate cancer	2.4e-05	0.000133	CcSEcCtD
Pilocarpine—Paraesthesia—Doxorubicin—prostate cancer	2.38e-05	0.000132	CcSEcCtD
Pilocarpine—Dyspnoea—Doxorubicin—prostate cancer	2.36e-05	0.000131	CcSEcCtD
Pilocarpine—Feeling abnormal—Epirubicin—prostate cancer	2.36e-05	0.000131	CcSEcCtD
Pilocarpine—Somnolence—Doxorubicin—prostate cancer	2.35e-05	0.000131	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Epirubicin—prostate cancer	2.34e-05	0.00013	CcSEcCtD
Pilocarpine—Dyspepsia—Doxorubicin—prostate cancer	2.33e-05	0.000129	CcSEcCtD
Pilocarpine—Vomiting—Prednisone—prostate cancer	2.33e-05	0.000129	CcSEcCtD
Pilocarpine—Rash—Prednisone—prostate cancer	2.31e-05	0.000128	CcSEcCtD
Pilocarpine—Dermatitis—Prednisone—prostate cancer	2.31e-05	0.000128	CcSEcCtD
Pilocarpine—Decreased appetite—Doxorubicin—prostate cancer	2.3e-05	0.000128	CcSEcCtD
Pilocarpine—Headache—Prednisone—prostate cancer	2.29e-05	0.000127	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.29e-05	0.000127	CcSEcCtD
Pilocarpine—Constipation—Doxorubicin—prostate cancer	2.26e-05	0.000126	CcSEcCtD
Pilocarpine—Pain—Doxorubicin—prostate cancer	2.26e-05	0.000126	CcSEcCtD
Pilocarpine—Body temperature increased—Epirubicin—prostate cancer	2.26e-05	0.000126	CcSEcCtD
Pilocarpine—Abdominal pain—Epirubicin—prostate cancer	2.26e-05	0.000126	CcSEcCtD
Pilocarpine—Feeling abnormal—Doxorubicin—prostate cancer	2.18e-05	0.000121	CcSEcCtD
Pilocarpine—Nausea—Prednisone—prostate cancer	2.17e-05	0.000121	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Doxorubicin—prostate cancer	2.17e-05	0.00012	CcSEcCtD
Pilocarpine—Hypersensitivity—Epirubicin—prostate cancer	2.11e-05	0.000117	CcSEcCtD
Pilocarpine—Abdominal pain—Doxorubicin—prostate cancer	2.09e-05	0.000116	CcSEcCtD
Pilocarpine—Body temperature increased—Doxorubicin—prostate cancer	2.09e-05	0.000116	CcSEcCtD
Pilocarpine—Asthenia—Epirubicin—prostate cancer	2.05e-05	0.000114	CcSEcCtD
Pilocarpine—Pruritus—Epirubicin—prostate cancer	2.03e-05	0.000112	CcSEcCtD
Pilocarpine—Diarrhoea—Epirubicin—prostate cancer	1.96e-05	0.000109	CcSEcCtD
Pilocarpine—Hypersensitivity—Doxorubicin—prostate cancer	1.95e-05	0.000108	CcSEcCtD
Pilocarpine—Asthenia—Doxorubicin—prostate cancer	1.9e-05	0.000106	CcSEcCtD
Pilocarpine—Dizziness—Epirubicin—prostate cancer	1.89e-05	0.000105	CcSEcCtD
Pilocarpine—Pruritus—Doxorubicin—prostate cancer	1.87e-05	0.000104	CcSEcCtD
Pilocarpine—Vomiting—Epirubicin—prostate cancer	1.82e-05	0.000101	CcSEcCtD
Pilocarpine—Diarrhoea—Doxorubicin—prostate cancer	1.81e-05	0.000101	CcSEcCtD
Pilocarpine—Rash—Epirubicin—prostate cancer	1.8e-05	0.0001	CcSEcCtD
Pilocarpine—Dermatitis—Epirubicin—prostate cancer	1.8e-05	0.0001	CcSEcCtD
Pilocarpine—Headache—Epirubicin—prostate cancer	1.79e-05	9.96e-05	CcSEcCtD
Pilocarpine—Dizziness—Doxorubicin—prostate cancer	1.75e-05	9.72e-05	CcSEcCtD
Pilocarpine—Nausea—Epirubicin—prostate cancer	1.7e-05	9.44e-05	CcSEcCtD
Pilocarpine—Vomiting—Doxorubicin—prostate cancer	1.68e-05	9.35e-05	CcSEcCtD
Pilocarpine—Rash—Doxorubicin—prostate cancer	1.67e-05	9.27e-05	CcSEcCtD
Pilocarpine—Dermatitis—Doxorubicin—prostate cancer	1.67e-05	9.26e-05	CcSEcCtD
Pilocarpine—Headache—Doxorubicin—prostate cancer	1.66e-05	9.21e-05	CcSEcCtD
Pilocarpine—Nausea—Doxorubicin—prostate cancer	1.57e-05	8.73e-05	CcSEcCtD
Pilocarpine—CHRM1—Signaling Pathways—ERBB3—prostate cancer	4.41e-06	5.48e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FGFR2—prostate cancer	4.4e-06	5.47e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ERBB3—prostate cancer	4.4e-06	5.46e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FGFR2—prostate cancer	4.39e-06	5.45e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	4.38e-06	5.44e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ERBB3—prostate cancer	4.35e-06	5.41e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FGFR2—prostate cancer	4.35e-06	5.4e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PLCB2—prostate cancer	4.34e-06	5.39e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—LRP2—prostate cancer	4.34e-06	5.39e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.34e-06	5.39e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—INS—prostate cancer	4.29e-06	5.32e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—MTHFR—prostate cancer	4.26e-06	5.29e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—P4HB—prostate cancer	4.26e-06	5.29e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CG—prostate cancer	4.25e-06	5.27e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL2—prostate cancer	4.24e-06	5.27e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL2—prostate cancer	4.23e-06	5.25e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TERT—prostate cancer	4.23e-06	5.25e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TERT—prostate cancer	4.21e-06	5.23e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CREBBP—prostate cancer	4.2e-06	5.21e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL2—prostate cancer	4.19e-06	5.2e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PPARA—prostate cancer	4.18e-06	5.19e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TERT—prostate cancer	4.17e-06	5.18e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.14e-06	5.14e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HIF1A—prostate cancer	4.04e-06	5.02e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.03e-06	5.01e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HIF1A—prostate cancer	4.03e-06	5.01e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—INS—prostate cancer	4.02e-06	4.99e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HIF1A—prostate cancer	3.99e-06	4.96e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CD—prostate cancer	3.98e-06	4.94e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—MED12—prostate cancer	3.97e-06	4.93e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—LEP—prostate cancer	3.95e-06	4.9e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GNG5—prostate cancer	3.94e-06	4.89e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CREBBP—prostate cancer	3.94e-06	4.89e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—LEP—prostate cancer	3.93e-06	4.89e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CAV1—prostate cancer	3.93e-06	4.88e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CAV1—prostate cancer	3.91e-06	4.86e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CAV1—prostate cancer	3.9e-06	4.84e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—LEP—prostate cancer	3.9e-06	4.84e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KDR—prostate cancer	3.87e-06	4.8e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CAV1—prostate cancer	3.86e-06	4.79e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KDR—prostate cancer	3.85e-06	4.79e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KDR—prostate cancer	3.82e-06	4.74e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NCOA3—prostate cancer	3.79e-06	4.71e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ESR1—prostate cancer	3.77e-06	4.68e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NOS3—prostate cancer	3.76e-06	4.67e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ESR1—prostate cancer	3.76e-06	4.67e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CD—prostate cancer	3.73e-06	4.64e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ESR1—prostate cancer	3.72e-06	4.62e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—BAD—prostate cancer	3.68e-06	4.57e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—BAD—prostate cancer	3.67e-06	4.55e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—BAD—prostate cancer	3.63e-06	4.51e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HPGDS—prostate cancer	3.62e-06	4.49e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.6e-06	4.47e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CG—prostate cancer	3.58e-06	4.44e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CG—prostate cancer	3.56e-06	4.42e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—APC—prostate cancer	3.56e-06	4.42e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CG—prostate cancer	3.55e-06	4.41e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—APC—prostate cancer	3.55e-06	4.41e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NOS3—prostate cancer	3.53e-06	4.38e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IRS1—prostate cancer	3.52e-06	4.37e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EGF—prostate cancer	3.52e-06	4.37e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—APC—prostate cancer	3.52e-06	4.37e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	3.52e-06	4.37e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTT1—prostate cancer	3.51e-06	4.36e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ACHE—prostate cancer	3.51e-06	4.36e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EGF—prostate cancer	3.51e-06	4.36e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IRS1—prostate cancer	3.51e-06	4.36e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EGF—prostate cancer	3.48e-06	4.32e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IRS1—prostate cancer	3.48e-06	4.32e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CB—prostate cancer	3.47e-06	4.31e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.47e-06	4.31e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTGS2—prostate cancer	3.44e-06	4.27e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GSK3B—prostate cancer	3.42e-06	4.25e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GSK3B—prostate cancer	3.41e-06	4.23e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—INS—prostate cancer	3.39e-06	4.21e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.38e-06	4.19e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GSK3B—prostate cancer	3.37e-06	4.19e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—INS—prostate cancer	3.37e-06	4.19e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—INS—prostate cancer	3.36e-06	4.17e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PRKACB—prostate cancer	3.36e-06	4.17e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—INS—prostate cancer	3.33e-06	4.13e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.32e-06	4.13e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CREBBP—prostate cancer	3.32e-06	4.12e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CREBBP—prostate cancer	3.3e-06	4.1e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CREBBP—prostate cancer	3.29e-06	4.09e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IGF1—prostate cancer	3.26e-06	4.05e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CREBBP—prostate cancer	3.26e-06	4.05e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CB—prostate cancer	3.25e-06	4.04e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IGF1—prostate cancer	3.25e-06	4.04e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—EGFR—prostate cancer	3.25e-06	4.03e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—EGFR—prostate cancer	3.24e-06	4.02e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTGS2—prostate cancer	3.22e-06	4e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IGF1—prostate cancer	3.22e-06	4e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—EGFR—prostate cancer	3.2e-06	3.98e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NCOA2—prostate cancer	3.17e-06	3.93e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAP2K1—prostate cancer	3.15e-06	3.92e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CD—prostate cancer	3.15e-06	3.91e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAP2K1—prostate cancer	3.14e-06	3.9e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CD—prostate cancer	3.13e-06	3.89e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CD—prostate cancer	3.12e-06	3.88e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	3.11e-06	3.86e-05	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—PIK3CA—prostate cancer	3.1e-06	3.85e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SERPINE1—prostate cancer	3.1e-06	3.85e-05	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—PIK3CA—prostate cancer	3.09e-06	3.84e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	3.09e-06	3.84e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SERPINE1—prostate cancer	3.09e-06	3.83e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—KRAS—prostate cancer	3.07e-06	3.81e-05	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	3.06e-06	3.8e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	3.06e-06	3.8e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—KRAS—prostate cancer	3.06e-06	3.8e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—KRAS—prostate cancer	3.03e-06	3.76e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.02e-06	3.75e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FGF2—prostate cancer	3e-06	3.72e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTEN—prostate cancer	3e-06	3.72e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FGF2—prostate cancer	2.99e-06	3.71e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NOS3—prostate cancer	2.97e-06	3.69e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FGF2—prostate cancer	2.96e-06	3.68e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NOS3—prostate cancer	2.96e-06	3.67e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.95e-06	3.66e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NOS3—prostate cancer	2.95e-06	3.66e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NOS3—prostate cancer	2.92e-06	3.63e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NQO1—prostate cancer	2.92e-06	3.62e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TH—prostate cancer	2.87e-06	3.57e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—JAK2—prostate cancer	2.87e-06	3.57e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—JAK2—prostate cancer	2.86e-06	3.56e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—EP300—prostate cancer	2.86e-06	3.55e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—JAK2—prostate cancer	2.84e-06	3.52e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	2.82e-06	3.5e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTEN—prostate cancer	2.81e-06	3.49e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PIK3CA—prostate cancer	2.81e-06	3.49e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MDM2—prostate cancer	2.81e-06	3.48e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.8e-06	3.47e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MDM2—prostate cancer	2.8e-06	3.47e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	2.78e-06	3.45e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MDM2—prostate cancer	2.77e-06	3.44e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ERBB2—prostate cancer	2.77e-06	3.44e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ERBB2—prostate cancer	2.76e-06	3.42e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CB—prostate cancer	2.74e-06	3.41e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ERBB2—prostate cancer	2.73e-06	3.39e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	2.73e-06	3.39e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CB—prostate cancer	2.72e-06	3.38e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTGS2—prostate cancer	2.72e-06	3.37e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GGT1—prostate cancer	2.71e-06	3.36e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	2.69e-06	3.35e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—EP300—prostate cancer	2.68e-06	3.33e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NCOA1—prostate cancer	2.67e-06	3.31e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.63e-06	3.27e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CXCL8—prostate cancer	2.62e-06	3.26e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CXCL8—prostate cancer	2.61e-06	3.25e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CXCL8—prostate cancer	2.59e-06	3.22e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	2.56e-06	3.18e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CDKN1B—prostate cancer	2.55e-06	3.17e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—RXRA—prostate cancer	2.54e-06	3.15e-05	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	2.53e-06	3.15e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	2.53e-06	3.14e-05	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	2.53e-06	3.14e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CASP3—prostate cancer	2.51e-06	3.12e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL2—prostate cancer	2.51e-06	3.11e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CASP3—prostate cancer	2.5e-06	3.11e-05	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	2.5e-06	3.11e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL2—prostate cancer	2.5e-06	3.1e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL6—prostate cancer	2.49e-06	3.1e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL6—prostate cancer	2.49e-06	3.09e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CASP3—prostate cancer	2.48e-06	3.08e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL2—prostate cancer	2.47e-06	3.07e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL6—prostate cancer	2.46e-06	3.06e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—COMT—prostate cancer	2.44e-06	3.04e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCND1—prostate cancer	2.44e-06	3.04e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCND1—prostate cancer	2.44e-06	3.03e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTP1—prostate cancer	2.43e-06	3.02e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	2.42e-06	3.01e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCND1—prostate cancer	2.41e-06	3e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	2.41e-06	3e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ITPR1—prostate cancer	2.39e-06	2.97e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	2.39e-06	2.97e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MMP9—prostate cancer	2.37e-06	2.95e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTEN—prostate cancer	2.37e-06	2.94e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MMP9—prostate cancer	2.36e-06	2.94e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	2.36e-06	2.94e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PTEN—prostate cancer	2.36e-06	2.93e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	2.36e-06	2.93e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PTEN—prostate cancer	2.35e-06	2.92e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MMP9—prostate cancer	2.34e-06	2.91e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	2.33e-06	2.9e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PTEN—prostate cancer	2.33e-06	2.89e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—AKT1—prostate cancer	2.3e-06	2.86e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—AKT1—prostate cancer	2.29e-06	2.85e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	2.27e-06	2.82e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TYMS—prostate cancer	2.26e-06	2.81e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—EP300—prostate cancer	2.26e-06	2.81e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EP300—prostate cancer	2.25e-06	2.79e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EP300—prostate cancer	2.24e-06	2.78e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTM1—prostate cancer	2.24e-06	2.78e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EP300—prostate cancer	2.22e-06	2.76e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—LPL—prostate cancer	2.19e-06	2.73e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SRC—prostate cancer	2.19e-06	2.72e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SRC—prostate cancer	2.18e-06	2.71e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SRC—prostate cancer	2.16e-06	2.68e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—VEGFA—prostate cancer	2.13e-06	2.65e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—VEGFA—prostate cancer	2.12e-06	2.64e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.12e-06	2.63e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CA—prostate cancer	2.12e-06	2.63e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—STAT3—prostate cancer	2.11e-06	2.62e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	2.1e-06	2.61e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—STAT3—prostate cancer	2.1e-06	2.61e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ERCC2—prostate cancer	2.1e-06	2.61e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—STAT3—prostate cancer	2.08e-06	2.59e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CA—prostate cancer	1.98e-06	2.46e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.98e-06	2.45e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MYC—prostate cancer	1.96e-06	2.43e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TGFB1—prostate cancer	1.96e-06	2.43e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MYC—prostate cancer	1.95e-06	2.43e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TGFB1—prostate cancer	1.95e-06	2.42e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PPARA—prostate cancer	1.94e-06	2.41e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MYC—prostate cancer	1.93e-06	2.4e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	1.93e-06	2.4e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EGFR—prostate cancer	1.92e-06	2.38e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EGFR—prostate cancer	1.91e-06	2.37e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EGFR—prostate cancer	1.89e-06	2.35e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CAV1—prostate cancer	1.82e-06	2.26e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KRAS—prostate cancer	1.81e-06	2.25e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KRAS—prostate cancer	1.81e-06	2.24e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KRAS—prostate cancer	1.79e-06	2.22e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—AKT1—prostate cancer	1.73e-06	2.15e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.67e-06	2.08e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	1.66e-06	2.07e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.66e-06	2.06e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	1.66e-06	2.06e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	1.64e-06	2.04e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—AKT1—prostate cancer	1.62e-06	2.01e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TP53—prostate cancer	1.61e-06	2e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TP53—prostate cancer	1.6e-06	1.99e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TP53—prostate cancer	1.59e-06	1.97e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—INS—prostate cancer	1.57e-06	1.95e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.54e-06	1.91e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL6—prostate cancer	1.47e-06	1.83e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL6—prostate cancer	1.47e-06	1.82e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.46e-06	1.81e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL6—prostate cancer	1.45e-06	1.81e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NOS3—prostate cancer	1.38e-06	1.71e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—AKT1—prostate cancer	1.37e-06	1.7e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AKT1—prostate cancer	1.36e-06	1.69e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AKT1—prostate cancer	1.35e-06	1.68e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AKT1—prostate cancer	1.34e-06	1.67e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.27e-06	1.58e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.26e-06	1.57e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTEN—prostate cancer	1.1e-06	1.37e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—EP300—prostate cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.75e-07	9.63e-06	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AKT1—prostate cancer	6.33e-07	7.87e-06	CbGpPWpGaD
